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However, certain high-risk subgroups of patients
remain at elevated risk of complications and death
despite progressive advances in perioperative care and
myocardial protection.1 We have previously identified
left ventricular (LV) dysfunction as one of the most sig-
nificant independent predictors of operative mortality2
and low-output syndrome3 during coronary bypass
operations. We have noted both an increasing preva-
lence of patients presenting with preoperative LV dys-
function and an increasing profile of comorbidity and
other risk factors within this subgroup. We therefore
attempted to identify the independent predictors of
operative mortality and morbidity in patients with mod-
erate or severe LV dysfunction to permit more accurate
evaluation of risk in these patients and to direct the
development of novel strategies to improve outcomes.
O perative morbidity and mortality rates during coro-nary bypass surgery have decreased substantially
during the past 2 decades. The overall mortality rate of
patients undergoing coronary bypass operations at our
institution fell from 4.0% in 1982 to 2.2% in 1997.
Objectives: The prevalence of ventricular dysfunction in patients under-
going coronary operations, as well as the prevalence of other risk factors
in these patients, has been increasing. We identified the predictors of
mortality and morbidity in patients with ventricular dysfunction to per-
mit more accurate evaluation of risk and to direct future strategies to
improve outcomes. Methods: Demographic, intraoperative, and outcome
data were collected prospectively on 20,614 patients undergoing isolated
coronary operations at our institution from 1982-1997. Multivariable
regression analyses were used to identify the independent predictors of
mortality and low-output syndrome. Results: Moderate ventricular dys-
function (ejection fraction, 20%-40%) was noted in 4107 (19.9%)
patients, and severe dysfunction (ejection fraction, <20%) was noted in
680 (3.3%) patients. Patients with worse ventricular function had an
increasing prevalence of other risk factors with time. Mortality
decreased between the 1982-1986 and 1987-1991 cohorts but did not
decrease further. Low-output syndrome was less common in the 1992-
1997 cohort than in previous years. The predictors of mortality were
ventricular dysfunction, age, reoperation, year of operation, urgency,
female sex, and left main stenosis. Low-output syndrome was predicted
by ventricular dysfunction, reoperation, year of operation, female sex,
urgency, extensive coronary disease, age, left main stenosis, and symp-
tom class. Conclusions: Despite the increasing prevalence and risk profile
of patients with ventricular dysfunction, mortality rates and incidence
of low-output syndrome declined with time. Patients with severe dys-
function were at greatest risk when facing reoperation or urgent opera-
tion. Earlier intervention and more aggressive preoperative optimiza-
tion may improve outcomes in these high-risk patients. (J Thorac
Cardiovasc Surg 1999;118:1006-13)
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Methods
Data source. Demographic, anatomic, intraoperative, and
in-hospital outcome data were collected prospectively and
entered into a computerized database on all patients undergo-
ing cardiac surgery at our institution (The Toronto Hospital,
formerly the Toronto General and Toronto Western Hospi-
tals). From this database, the records of all patients undergo-
ing isolated coronary artery bypass grafting between
January 1, 1982, and December 31, 1997, were retrieved for
analysis.
Core fields collected in our database since its inception in
1982 included age, sex, LV grade (based on LV ejection frac-
tion [LVEF]: grade 1, LVEF >60%; grade 2, LVEF 40%-
60%; grade 3, LVEF 20%-39%; and grade 4, LVEF < 20%),
previous coronary artery bypass operations, urgency of the
operation (elective; semiurgent, indicating surgery during the
same admission as cardiac catheterization or a cardiac event;
or emergency, indicating surgery within 12 hours of cardiac
catheterization or a cardiac event), number of coronary arter-
ies with significant stenoses, left main stenosis of greater than
50%, severity of angina, and New York Heart Association
(NYHA) functional class. LVEF was determined semiquanti-
tatively by contrast ventriculography. Echocardiography and
nuclear ventriculography were carried out in a minority of
patients, and when these additional data were available, the
greatest value for LVEF obtained was used for subsequent
analysis. In the minority of patients in whom these estimates
differed, this was generally caused by performance of one
study within 1 to 3 days after a myocardial infarction, result-
ing in overestimation of LV dysfunction, with a subsequent
Table I. Number of patients by year of operation and LVEF
1982-1986 1987-1991 1992-1997 All years
LVEF > 40% 4582 (78.5%) 4554 (76.8%) 6465 (75.0%) 15,601
LVEF 20%-40% 1072 (18.4%) 1162 (19.6%) 1873 (21.7%) 4107
LVEF < 20% 186 (3.2%) 216 (3.6%) 278 (3.2%) 680
All patients 5840 5932 8616 20,388
Table II. Demographic details of 20,388 patients by LVEF
LVEF > 40% LVEF 20%-40% LVEF < 20% P value
Age (y) 60.3 ± 9.7 61.2 ± 9.7 60.2 ± 9.6 <.0001
Sex (% male) 78.9 83.8 86.2 <.0001
NYHA class 2.6/17.7/39.8/39.9 2.3/11.5/36.7/49.5 1.6/8.4/31.5/58.5 <.0001
(% I/II/III/IV)
No. of diseased vessels 6.4/23.5/70.1 2.1/17.6/80.3 2.2/16.7/81.1 <.0001
(% 1/2/3)
Left main stenosis (%) 16.4 15.8 20.4 .01
Reoperative surgery (%) 5.2 8.7 7.5 <.0001
Preoperative MI  19.2 33.2 35.9 <.0001
<30 days (%)
Preoperative IABP (%) 2.7 4.6 8.1 <.0001
Urgency (% elective/ 69.1/16.9/14.0 62.9/19.7/17.4 60.4/17.4/22.2 <.0001
urgent/emergency)
MI, Myocardial infarction.
Table III. Intraoperative details of 20,388 patients by LVEF
LVEF > 40% LVEF 20%-40% LVEF < 20% P value
No. of grafts 3.1/13.1/35.7/37.7 1.4/10.1/35.3/42.5 2.4/11.3/34.6/43.4
(% 1/2/3/4)
No. of grafts (% 5/6/7) 9.9/0.4/0.01 9.9/0.7/0.07 8.2/0.2/0.0 <.0001
LITA (% 1982-1997) 69.3 65.1 54.0 <.0001
LITA (% 1992-1997, 89.1 83.2 73.0 <.0001
8614 patients)
CPB time (min) 86.3 ± 30.7 91.7 ± 28.5 99.6 ± 35.2 <.0001
Crossclamp time 56.9 ± 20.3 59.7 ± 18.6 60.2 ± 19.4 <.0001
(min)
CPB, Cardiopulmonary bypass.
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study showing partial recovery of contractility. In these cases
the later study (always resulting in a higher estimated LVEF)
was used for analysis. Core data were complete on 20,388
(98.9%) of 20,614 patients.
Analysis. Data were collected and managed in dBASE IV
datasets and analyzed with SAS and BMDP/DYN LR statis-
tical analysis software (SAS Institute, Inc, Cary, NC; BMDP
Software, Los Angeles, Calif). Univariate analysis of cate-
gorical data was carried out by using c 2 analysis or the Fisher
exact test. Univariate analysis of continuous variables was
carried out by using the Student t test. Variables that had a
univariate P value of less than .25 or those of known biolog-
ic importance but failing to meet the critical a level were sub-
mitted for consideration to logistic regression analysis by
using stepwise selection. Multivariable logistic regression
methods were used to calculate risk-adjusted mortality rates
and factor-adjusted odds ratios. Model discrimination was
evaluated by the area under the receiver-operator characteris-
tic curve, and calibration was assessed with the Hosmer-
Lemeshow goodness-of-fit statistic. For goodness-of-fit, the
null hypothesis is that the model fits the data. Therefore a
nonsignificant P value is desired because P values of less
than .05 would indicate a poor fit between predicted and
observed results.
Evaluation of temporal trends. Rather than constructing
a complex model to assess the temporal trends in prevalence,
risk profiles, and outcomes, we used a simpler approach
based on risk stratification and contingency tables. To exam-
ine the effect of time on patient risk profiles and outcomes,
patients were divided into 3 groups based on the year of oper-
ation (1982-1986, 1987-1991, and 1992-1997). Contingency
table analysis was then used to examine changes in the preva-
lence of LV dysfunction, risk factors, and operative mortality
over time and among the 3 risk groups.
Results
Demographics 
Prevalence of LV dysfunction. A total of 15,601
patients had no or only mild LV dysfunction (LVEF >
40% for 75.7% of all patients), whereas 4107 (19.9%)
patients had moderate dysfunction (LVEF 20%-40%),
and 680 (3.3%) patients had severe dysfunction (LVEF
< 20%). The number of patients, categorized by LVEF
and by year of operation, is shown in Table I. The pro-
portion of patients presenting with an LVEF of 20% to
40% increased from 18.4% in 1982-1986 to 21.7% in
1992-1997, but the proportion of patients with an
LVEF of less than 20% remained constant.
Additional risk factors in patients with LV dysfunc-
tion. Demographic details, grouped by degree of LV
dysfunction, are listed in Table II. Patients with worse
LV function were more likely to be male and to have
more extensive coronary disease or left main coronary
artery stenosis. The acuity of patients with worse LV
function was greater, with higher NYHA symptom
class and a greater likelihood of requiring an urgent or
emergency operation. The prevalence of preoperative
intra-aortic balloon pump (IABP) support was greatest
in patients with severe ventricular dysfunction. These
patients were therefore more likely to require an urgent
or emergency operation.
Increasing risk profile of patients with LV dysfunc-
tion. In more recent years, patients with LVEF of less
than 20% were older and more symptomatic (Fig 1).
They were also more likely to have left main stenosis
(P = .01) and to require an urgent or emergency opera-
tion, although the trend to more urgent operation did
not reach statistical significance.
Patients with an LVEF of 20% to 40% demonstrated
a similar statistically significant increase in patient age,
symptom class, left main stenosis, and need for urgent
or emergency operation. In addition, in this subgroup
there was also an increasing number of female patients
(1982-1986, 13.9%; 1987-1991, 15.7%; and 1992-
1997, 17.8%; P = .02) and a greater prevalence of reop-
erative surgery (1982-1986, 6.2%; 1987-1991, 9.6%;
and 1992-1997, 9.6%; P = .003).
Intraoperative data. Intraoperative details, grouped
by degree of LV dysfunction, are listed in Table III.
Fig 1. The prevalence of operative risk factors in 20,614
patients undergoing isolated coronary artery bypass grafting
over 3 time periods (1982-1986, 1987-1991, and 1992-1997).
Patient age and symptom class increased significantly with
more recent year of operation, as did the prevalence of left
main coronary artery stenosis and the requirement for an
urgent or emergency operation. LM, Left main; Non-elective,
Requiring urgent or emergency surgery.
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Although overall use of the left internal thoracic artery
(LITA) increased with year of operation (1982-1986,
36.0%; 1987-1991, 70.6%; and 1992-1997, 87.3%; P <
.0001), patients with worse LV function were less like-
ly to receive an internal thoracic artery (ITA) graft in
any year.
Most patients received 3 or 4 bypass grafts. The dura-
tion of cardiopulmonary bypass was greater in patients
with worse ventricular function (Table III). The dura-
tion of aortic crossclamping was similar between
groups, ranging from approximately 57 to 60 minutes.
In earlier years, systemic perfusion was carried out at
moderate hypothermia (1982-1986: 25°C-29°C for
96% and 30°C-35°C for 4% of patients) but our routine
is now to use only mild hypothermia (1992-1997:
25°C-29°C for 9%, 30°C-35°C for 82%, and 36°C-
37°C for 9% of patients; P < .0001 vs 1982-1986). The
degree of systemic hypothermia was not different, how-
ever, between LVEF groups. Antegrade cold blood car-
dioplegia was used for myocardial protection in 91% to
95% of patients over the 3 time periods; the technique
of cardioplegia was not different between LVEF
groups.
Outcomes
Operative mortality rates. The overall operative mor-
tality rate increased with greater LV dysfunction (P <
.0001; Fig 2). Mortality decreased between the 1982-
1986 and 1987-1991 cohorts in all LVEF groups but did
not decrease further in the 1992-1997 cohort (Fig 3).
Myocardial infarction. The rate of perioperative
myocardial infarction was not different between LVEF
groups (LVEF > 40%, 3.8%; LVEF 20-40%, 4.0%; and
LVEF < 20%, 4.9%; P = .4).
Low-output syndrome. Postoperative low cardiac out-
put syndrome (the requirement for inotropic or IABP
support to maintain a cardiac index of greater than 2.0
L · min–1 · m–2 despite optimization of heart rate, pre-
load, and afterload) was significantly greater in patients
with LV dysfunction (P < .0001; Fig 2).
The rate of low-output syndrome fell between the
1987-1991 and 1992-1997 cohorts, but even in the lat-
est cohort, low-output syndrome was still 4 times as
common in patients with LVEFs of less than 20% as it
was in patients with LVEFs of greater than 40% (P <
.0001; Fig 4).
IABP support. Placement of an IABP preoperatively
Fig 2. Operative mortality rate and incidence of postoperative
low-output syndrome, as determined by preoperative LVEF.
Mortality rate was low in patients with no or minimal ven-
tricular dysfunction but doubled when LVEF was 20% to
40% and was more than quadrupled in patients with LVEFs
of less than 20%. Low-output syndrome was uncommon in
patients with no or minimal ventricular dysfunction but was
twice as common when LVEFs were 20% to 40% and 3 times
as common in patients with LVEFs of less than 20%.
Fig 3. Operative mortality rates, as determined by preopera-
tive LVEF, over 3 time periods (1982-1986, 1987-1991, and
1992-1997). Mortality decreased from the 1982-1986 cohort
to the 1987-1991 cohort in all LVEF groups, but the reduction
was most marked in patients with LVEFs of less than 40%.
No further reduction in mortality rate was noted from the
1987-1991 cohort to the 1992-1997 cohort.
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in the coronary care unit for refractory angina or car-
diogenic shock was required more often in patients
with LV dysfunction (LVEF > 40%, 2.7%; LVEF 20%-
40%, 4.6%; and LVEF < 20%, 8.1%; P < .0001).
Surgeons were also more likely to place an IABP pro-
phylactically in the operating room before commence-
ment of the surgical procedure to provide perioperative
support in patients with poor ventricular function
(LVEF > 40%, 0.9%; LVEF 20%-40%, 1.7%; and
LVEF < 20%, 9.3%; P < .0001). Postoperative place-
ment of an IABP (whether in the operating room at the
conclusion of the surgical procedure or in the intensive
care unit) for hemodynamic support was also related to
the degree of ventricular dysfunction (LVEF > 40%,
3.8%; LVEF 20%-40%, 8.5%; and LVEF < 20%,
13.8%; P < .0001).
Other outcomes. Perioperative cerebrovascular acci-
dents were more common with greater LV impairment
(LVEF > 40%, 1.4%; LVEF 20%-40%, 2.5%; and
LVEF < 20%, 3.8%; P < .0001). Deep sternal infec-
tions were also more common in patients with greater
LV dysfunction (LVEF > 40%, 1.9%; LVEF 20%-40%,
3.1%; and LVEF < 20%, 3.2%; P < .0001). In general,
deep sternal infection rates have fallen with time; in
1997, only 0.7% of patients undergoing coronary artery
bypass grafting developed sternal osteomyelitis.
Predictors of operative mortality and low-output
syndrome
Independent predictors of operative mortality by
LVEF. Preoperative patient variables that were univari-
ate predictors of operative mortality and variables of
known biologic importance not meeting the critical a
level were entered into a multivariable regression
model for the entire patient cohort. The independent
predictors of mortality were greater LV dysfunction,
increased age, reoperative surgery, earlier year of oper-
ation, urgent surgery, female sex, and left main steno-
sis (Table IV).
Fig 4. The prevalence of postoperative low-output syndrome,
as determined by preoperative LVEF, over 3 time periods
(1982-1986, 1987-1991, and 1992-1997). Low-output syn-
drome decreased with time in all LVEF groups but only from
the 1987-1991 cohort to the 1992-1997 cohort.
Table IV. Multivariable predictors of operative mor-
tality in all 20,614 patients
Regression 
Variable coefficient OR 95% CI
Constant –0.9659 ± 0.911
Age 0.0464 ± 0.005 1.048 1.037-1.058
LV grade 0.5385 ± 0.051 1.713 1.550-1.894
NYHA class 0.3301 ± 0.078 1.391 1.193-1.622
Reoperative surgery 1.0538 ± 0.128 2.869 2.234-3.683
Urgency 0.4340 ± 0.074 1.543 1.334-1.786
Year of operation –0.0997 ± 0.010 0.905 0.887-0.924
Female sex 0.5601 ± 0.099 1.751 1.441-2.127
Left main stenosis 0.4737 ± 0.105 1.606 1.309-1.971
The area under the receiver-operator characteristic curve was 0.754. The
Hosmer-Lemeshow goodness-of-fit P value was .375.
LV grade: 1, LVEF > 60%; 2, LVEF 40%-60%; 3, LVEF 20%-40%; 4, LVEF <
20%. Urgency: 0, Elective; 1, same hospitalization; 2, within 12 hours of a car-
diac catheterization or cardiac event (eg, myocardial infarction and unstable
angina). Year of operation: 1982-1997. OR, Odds ratio; CI, confidence interval.
Table V. Multivariable predictors of low-output syn-
drome in all 20,614 patients
Regression 
Variable coefficient OR 95% CI
Constant 0.7957 ± 0.511
Age 0.0246 ± 0.003 1.025 1.109-1.031
LV grade 0.4469 ± 0.030 1.563 1.475-1.657
NYHA class 0.0949 ± 0.040 1.100 1.017-1.189
Reoperative surgery 1.1951 ± 0.078 3.304 2.838-3.846
Urgency 0.4214 ± 0.046 1.524 1.393-1.668
Year of operation –0.0884 ± 0.006 0.915 0.905-0.926
Female sex 0.7325 ± 0.058 2.080 1.858-2.330
Left main stenosis 0.2311 ± 0.064 1.260 1.111-1.429
Extent of coronary 0.3394 ± 0.051 1.404 1.270-1.552
artery disease
The area under the receiver-operator characteristic curve was 0.719. The
Hosmer-Lemeshow goodness-of-fit P value was .673.
LV grade: 1, LVEF > 60%; 2, LVEF 40%-60%; 3, LVEF 20%-40%; 4, LVEF <
20%. Urgency: 0, Elective; 1, same hospitalization; 2, within 12 hours of a car-
diac catheterization or cardiac event (eg, myocardial infarction and unstable angi-
na). Year of operation: 1982-1997. Extent of coronary artery disease: Number of
diseased vessels (0, 1, 2, or 3). OR, Odds ratio; CI, confidence interval.
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In patients with LVEFs of 20% to 40%, the indepen-
dent predictors of mortality were reoperative surgery
(c 2, 38.09; P < .0001), earlier year of operation (c 2,
26.81; P < .0001), female sex (c 2, 17.72; P < .0001),
urgent surgery (c 2, 15.48; P = .0004), and increased
age (c 2, 13.15; P = .001).
For the smallest group of patients, with the greatest
LV impairment (LVEF < 20%), the only significant
independent predictors were urgent surgery (c 2, 16.43;
P = .0003) and reoperative surgery (c 2, 5.38; P = .02).
Independent predictors of low-output syndrome by
LVEF. Preoperative patient variables that were predic-
tive of postoperative low cardiac output syndrome in
the entire patient cohort are listed in Table V.
In patients with LVEFs of 20% to 40%, the indepen-
dent predictors of low-output syndrome were reopera-
tive surgery (c 2, 87.63; P < .0001), earlier year of oper-
ation (c 2, 55.29; P < .0001), female sex (c 2, 54.18; P <
.0001), urgent surgery (c 2, 33.11; P < .0001), more
extensive coronary disease (c 2, 14.18; P = .0008),
increased age (c 2, 11.61; P = .003), and NYHA class
(c 2, 8.34; P = .04).
In patients with LVEFs of less than 20%, the predic-
tors of low-output syndrome were urgent surgery (c 2,
16.62; P = .0002), left main stenosis (c 2, 8.06; P =
.004), earlier year of operation (c 2, 7.95; P = .02), and
reoperative surgery (c 2, 5.22; P = .02).
Discussion
In our experience LV dysfunction has been the most
significant independent predictor of operative mortality
and postoperative low-output syndrome. In the 16-year
time span from 1982-1997, we noted an increasing
prevalence of moderate-to-severe LV dysfunction in
patients referred for coronary artery bypass grafting.
This increase may have been due to the widespread
application of thrombolysis, increasing the number of
patients surviving acute myocardial infarctions to
require revascularization, and of angioplasty, which
may delay surgical revascularization until coronary ath-
erosclerosis is more extensive and ventricular dysfunc-
tion is more severe. The risk profile of patients referred
for coronary bypass surgery has increased with time,1
and this trend has been particularly marked in patients
with preoperative ventricular dysfunction. In the later
years of this series, patients with LVEFs of less than
40% were older, more symptomatic, more likely to
have left main stenosis, and more likely to require
urgent or reoperative surgery. All of these factors have
also been identified as independent predictors of oper-
ative mortality,2 low-output syndrome,3 or both.
The operative mortality rate decreased in all patients
between the 1982-1986 and 1987-1991 cohorts, and
the decline was most marked in patients with LVEFs of
less than 40%. However, no further reduction in the
mortality rate was noted from the 1987-1991 cohort to
the 1992-1997 cohort. During this most recent decade,
incremental improvements in perioperative patient
management were offset by the increasing risk profile
of patients with LVEFs of less than 40%, resulting in
stable overall mortality rates. Estefanous and col-
leagues4 have reported a comparison of 2 cohorts of
patients undergoing coronary artery bypass grafting
(1986-1988 vs 1993-1994) from the Cleveland Clinic
and also noted an increasing risk profile with time. The
gross mortality rate was greater in the more recent
cohort, but the risk-adjusted mortality rate was
unchanged. Smaller single-institution series have
reported variable results in patients with moderate-to-
severe ventricular dysfunction; Baumgartner and col-
leagues5 reported an overall mortality rate of 8% in 61
patients with LVEFs of less than 25% undergoing coro-
nary artery bypass grafting, and Elefieriades and col-
leagues6 had a mortality rate of 5.2% in 135 patients
with LVEFs of less than 30%. Mickleborough and col-
leagues7 reported a mortality rate of only 3.8% in 79
patients with severe LV dysfunction (mean LVEF
18%). These results were attributed in part to careful
myocardial temperature mapping with cold cardiople-
gia to maintain myocardial protection.
Earlier year of operation was an independent predic-
tor of both operative mortality and postoperative low-
output syndrome in patients with LVEFs of 20% to
40%. Year of operation did not predict outcomes in
patients with LVEFs of less than 20%, but this may
have been due to the much smaller number of patients
in this group. This time-related improvement may have
been due to progressive advances in anesthetic tech-
nique, myocardial protection, and postoperative inten-
sive care. Most surgeons at our institution have used
intermittent cold antegrade blood cardioplegia as a
standard technique of myocardial protection for coro-
nary artery bypass grafting, adding retrograde cardio-
plegia for specific anatomic indications or for ongoing
myocardial ischemia. Tepid (29°C)8 or warm (37°C)9,10
blood cardioplegia was used in a minority of patients
and only since 1990, and the effect of cardioplegia tem-
perature on operative outcomes is therefore difficult to
determine in this cohort. However, a terminal hot shot
of warm blood cardioplegia before crossclamp removal
was universally adopted by our surgeons in 1987-1988
after a randomized clinical trial demonstrated
improved perioperative myocardial metabolism and
function with this technique.11 This consistent change
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to our institutional strategy of myocardial protection
may have contributed to the overall improvement in
results noted with time and particularly to the decrease
in the prevalence of low-output syndrome from the
1987-1991 cohort to the 1992-1997 group. However,
because the adoption of the hot shot was so directly
related to year of operation, it was not possible to sep-
arate the effects of these 2 factors in our analyses.
During the 16 years from 1982-1997, overall use of
the LITA as a bypass conduit increased markedly, but
patients with worse ventricular function were less like-
ly to receive an ITA graft regardless of the year of oper-
ation. Although the reason for not using an ITA graft
was not recorded in our database, a number of concerns
about the short-term limitations of ITA grafts may have
made surgeons more likely to use venous conduits in
these high-risk patients. These considerations may
have included the time required for ITA harvesting in
unstable patients, lower initial flow compared with vein
grafts, the potential for spasm (particularly in patients
likely to receive vasoactive inotropic agents), and the
inability to deliver cardioplegic solution down a pedi-
cled arterial graft. In addition, the relative benefit of
use of the LITA on late mortality rate, myocardial
infarction, and reintervention in the setting of severe
ventricular dysfunction has not been well established.
The reduced late survival associated with LV dysfunc-
tion, advanced age, and significant comorbidity in
these patients may offset the survival advantage gener-
ally associated with LITA use. Selection bias may
account for the lower operative mortality and morbidi-
ty rates associated with LITA use in some series.
Baumgartner and colleagues5 have suggested that the
indications for and results of its use in this subgroup of
patients have been poorly documented and require fur-
ther investigation. Despite these concerns, a number of
recent studies have reported LITA use in 76% to 86%
of patients with ventricular dysfunction, with excellent
initial results.6,7 Other recent series quote its use in as
few as 41% of patients.5 Canver and colleagues12
reported a diminished survival benefit with use of the
LITA conduit in patients with LV dysfunction. Early
outcomes were not influenced by its use, and it was not
established if use of the LITA in the setting of ventric-
ular compromise was deleterious. Anderson and col-
leagues13 reported use of the LITA in 70% of patients
with ventricular dysfunction presenting with chronic
congestive heart failure and reported that its use
enhanced late survival. Reports are conflicting, and the
magnitude of benefit of the LITA in patients with
severely depressed LVEFs remains to be definitively
established.
In patients with severe LV impairment (LVEF <
20%), the need for urgent surgery or reoperative
surgery were independent predictors of both operative
mortality and low-output syndrome. Earlier surgical
intervention in patients with progressive angina who
are known to have significant ventricular dysfunction
may reduce overall mortality rates and the prevalence
of low-output syndrome because acute myocardial
ischemia in patients requiring urgent revascularization
increases operative risk. Alternatively, more aggressive
intervention to treat ischemia and stabilize the patient
preoperatively may also improve outcomes. Dietl and
colleagues14 reported in a retrospective study that
patients with LVEFs of less than 25% in whom an
IABP was placed preoperatively had lower 30-day
mortality rates, shorter hospital stays, and lower hospi-
tal charges than patients without preoperative IABP
support. Christenson and colleagues15 reported that
preoperative IABP support in high-risk patients under-
going coronary artery bypass grafting, 87% of whom
had LVEFs of less than 40%, resulted in lower opera-
tive mortality rates, lower requirements for inotropic
drugs, and shorter intensive care unit stays. Although
the low but finite complication rate of IABP insertion
may make elective placement of balloon pumps unde-
sirable in the majority of patients requiring urgent
coronary artery bypass grafting, it may be a reasonable
option in patients with severe LV impairment.
Cimochowski and colleagues16 reported that a combi-
nation of liberal use of IABP support in combination
with a cocktail of metabolic and mechanical support
strategies resulted in a remarkable 1.8% mortality rate
in 111 patients with LVEFs of 10% to 34%.
In patients with the most severe LV dysfunction,
often related to end-stage ischemic cardiomyopathy,
cardiac transplantation may be considered. However,
because of the continuing shortage of donor organs and
the consequences of long-term immunosuppression,
high-risk coronary artery bypass grafting may be con-
sidered for patients with adequate target vessels and
evidence of reversible ischemia on viability studies.
We, and other institutions, have used this strategy with
reasonable outcomes in this select patient popula-
tion.7,17 The presence of a large reversible thallium
defect is associated with a greater likelihood of
improvement in LVEF after revascularization. Chan
and colleagues18 noted that a large reversible thallium
defect predicted an improvement of 5% or more in
LVEF after coronary artery bypass grafting, with an
adjusted odds ratio of 15. Even a presentation with
symptoms of congestive heart failure alone, without
angina, does not necessarily indicate a fixed defect and
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a higher risk of operation. Anderson and colleagues13
reported a series of 203 patients with chronic conges-
tive heart failure but no angina and a mean LVEF of
34% in whom coronary artery bypass grafting was per-
formed with a hospital mortality rate of 6.0% and a 5-
year survival of 59%. In these patients transplantation
may still be offered if clinical improvement does not
occur with revascularization alone.
Our results suggest that although the risk of coronary
artery bypass grafting is generally low, patients with
significant ventricular dysfunction still face markedly
elevated operative morbidity and mortality rates.
Advances in operative technique, myocardial protec-
tion, and perioperative critical care have been offset by
a steadily increasing risk profile of patients referred for
surgical revascularization. In the presence of an LVEF
of less than 20%, the requirement for reoperation or
urgent operation poses a dramatically increased risk.
Attention to myocardial protection, meticulous surgical
technique, and perhaps routine preoperative IABP sup-
port are required to achieve optimal results in these
high-risk patients.
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